The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Drugs)·D-0122-2027·Announced 2026-11-11

Victory Medical Center Pharmacy Recalls Cagrilintide/Glycine/B12 Vials

Victory Medical Center Pharmacy is recalling 75 vials of Cagrilintide/Glycine/B12 (MDV) 3.75/5/1mg/mL due to lack of processing controls.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II due to a lack of processing controls. The source does not report any illnesses, injuries, or deaths.

Plain-English summary

Victory Medical Center Pharmacy in Austin, Texas, is recalling 75 vials of Cagrilintide/Glycine/B12 (MDV) 3.75/5/1mg/mL. The product is identified by Lot 2021027 with an expiration date of 10/19/2026.

The recall was initiated due to a lack of processing controls. The affected product was distributed in Colorado, Florida, and Texas.

Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for further instructions.

The recalled product

Product
CAGRILINTIDE/GLYCINE/B12 (MDV) 3.75/5/1MG/ML **1ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas
Affected units
75

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot
  • expiry: Lot 2021027
  • exp 10/19/2026

Distribution

Distributed in 3 states:

Similar recalls